Acurx Pharmaceuticals presented a study showing ibezapolstat (IBZ) outperforms vancomycin and fidaxomicin in killing Clostridioides difficile and vancomycin-resistant Enterococcus (VRE) in lab tests. IBZ maintained strong bactericidal activity even in complex co-cultures where Enterococcus impairs other antibiotics' effectiveness. It also reduced toxin B expression and VRE overgrowth, suggesting potential to improve treatment and reduce recurrence of C. difficile infection (CDI). The company is advancing IBZ into Phase 3 trials, aiming for FDA approval to treat and prevent recurrent CDI, a major healthcare challenge with high costs and mortality.
The story on Acurx Pharmaceuticals and its ibezapolstat study is presented here with relevant market data from Pluang's Health sector. For readers following health stocks, here is Pluang's market snapshot as of Sep 14, 2026 18:52 WIB: Among 91 priced health-sector US stocks, 50 rose and 28 fell. AstraZeneca plc (AZN) gained 1.80% to USD 163.06, contrasting with Twist Bioscience Corp (TWST) which declined 1.93% to USD 124.77, and Aurora Cannabis Inc (ACB) down 1.74% at USD 3.67.
MindWave Innovations Inc., a subsidiary of Apimeds Pharmaceuticals US, signed three agreements within 10 days to create dedicated blockchain networks for clients in climate finance, sports media, and insurance. Each network runs on MindWave's MindCha...
Park Aerospace reported Q2 fiscal 2027 earnings that exceeded expectations, with EPS of $0.21 versus $0.16 estimated and revenue of $20.8 million beating the $20 million forecast. The company showed strong profitability with a 34.3% gross margin and ...
On October 9, 2026, WF Holding's stock soared nearly 500% on extremely high volume despite no confirmed catalyst. Veea rose 47.3% after regaining full Nasdaq listing compliance by resolving governance issues. Fastly gained 15.9% following an Oppenhei...
First Commonwealth Financial Corporation announced it will hold a conference call and webcast on October 28, 2026, at 2:00 p.m. ET to discuss its third quarter 2026 financial results. The earnings press release will be published after market close on...
Brookfield Corporation announced it will release its third quarter 2026 financial results on November 12, 2026, at 7:00 a.m. ET, followed by a conference call and webcast at 10:00 a.m. ET. Investors and analysts can join the call via pre-registration...
